HopeStage
Back to all studies
CompletedNCT01114737

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Medication studyAges 8–65United States + CanadaADHD
The study in practice

Understand this study

Who was this study for?

Listed age limits: 8 years to 65 years.

Listed locations
La Jolla and 35 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2010
Recruitment status
Completed
Enrollment listed in the registry
206
Sponsor
BioMarin Pharmaceutical
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Canada
Age range
From 8 Years to 65 Years
Official registry ID
NCT01114737
Official title
Show the full official title

A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

La Jolla, United States · Los Angeles, United States · Palo Alto, United States

33 more locations
  • San Francisco, United States
  • Aurora, United States
  • Washington D.C., United States
  • Gainesville, United States
  • Tampa, United States
  • Atlanta, United States
  • Chicago, United States
  • Indianapolis, United States
  • Boston, United States
  • Minneapolis, United States
  • Albany, United States
  • Buffalo, United States
  • Rochester, United States
  • Chapel Hill, United States
  • Cleveland, United States
  • Portland, United States
  • Hershey, United States
  • Philadelphia, United States
  • Pittsburgh, United States
  • Nashville, United States
  • Dallas, United States
  • Madison, United States
  • Milwaukee, United States
  • Calgary, Canada
  • Edmonton, Canada
  • Vancouver, Canada
  • Winnipeg, Canada
  • Halifax, Canada
  • Hamilton, Canada
  • Kingston, Canada
  • London, Canada
  • Toronto, Canada
  • Montreal, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is BioMarin Pharmaceutical, a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including Sapropterin dihydrochloride and Placebo.

Who was this study for?

Listed age limits: 8 years to 65 years.

Want to explore more studies?

Explore studies